MLICM
MXCT icon

Metropolitan Life Insurance Company (MetLife)’s MaxCyte MXCT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,026
Closed -$21.1K – 1341
2024
Q1 		$21.1K Hold
5,026
– – ﹤0.01% 1834
2023
Q4 		$23.6K Hold
5,026
– – ﹤0.01% 1841
2023
Q3 		$15.7K Hold
5,026
– – ﹤0.01% 2005
2023
Q2 		$23.1K Hold
5,026
– – ﹤0.01% 1854
2023
Q1 		$24.9K Sell
5,026
-1,713
-25% -$8.44K ﹤0.01% 1768
2022
Q4 		$36.8K Hold
6,739
– – ﹤0.01% 1662
2022
Q3 		$43.8K Hold
6,739
– – ﹤0.01% 1551
2022
Q2 		$31.9K Hold
6,739
– – ﹤0.01% 1782
2022
Q1 		$47.1K Sell
6,739
-20,012
-75% -$137K ﹤0.01% 1637
2021
Q4 		$273K Buy
+26,751
New +$287K ﹤0.01% 1799

Other funds holding MXCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s MXCT Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of MaxCyte (MXCT) in Q2 2024, closing a stake of 5,026 shares — an estimated $21.1K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in MXCT in Q4 2021 and held it in 10 quarters. The position peaked at $273K in Q4 2021. 114 funds tracked by Wall St. Rank hold MXCT as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining MaxCyte position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 5,026 MaxCyte shares in Q2 2024, an estimated $21.1K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in MaxCyte in Q4 2021 and held it in 10 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s MaxCyte position peaked at $273K in Q4 2021.
  • 114 funds tracked by Wall St. Rank held MaxCyte as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.